ISLAMABAD: A revolutionary finding in treating and preventing Type 2 diabetes has rekindled the hope of millions of patients across the globe.
A recent article in Nature Communications reveals that researchers have unveiled a specific gene that is the main player in the onset of this disorder, thus creating a chance for significantly more powerful remedies in the future.
The study delineates the gene SMOC1 that interacts with the pancreas cells that clear blood sugars. The said gene’s action triggers these cells to switch from insulin to glucagon production, which in turn raises the blood sugar and makes the patient suffer more from the disease.
The investigation found that the beta cells which produce insulin in Type 2 diabetics, have their identity lost and then function like the alpha ones. In a healthy person, the beta and alpha cells collaborate to control blood sugar levels. But, in diabetes patients, this cooperation is disturbed which leads to a shortage of insulin and an excess of glucagon.
Professionals are certain that the grasp of this genetic mechanism could mark the end of the dark age in Type 2 diabetes treatments. Soon, medicines might be made to attack the disease at its roots, thus, allowing a potential release of the condition and an upgrade in the patients’ quality of life.
The study shines as a major victory in diabetes treatment and suggests that doctors might be able to give patients the right, personalized pharmaceutical multiplications in the near future.
ALSO READ: Drinking water on an empty stomach: A simple habit with big health benefits
